FIELD: medicine.
SUBSTANCE: there is developed a complex containing a V3-loop gpl20 and Tat HIV. There is disclosed a set containing such complex and a method of developing an immune response by means of such complexes. The invention can be used in medicine.
EFFECT: complex exhibits high immunogenicity that allows using it for treating or preventing HIV-infection.
27 cl, 3 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOGENIC COMPOSITION CONTAINING SYNTHETIC PEPTIDES REPEATING SEQUENCE OF V3-LOOP OF SHELL PROTEIN GP120 HIV1 | 2017 |
|
RU2694576C2 |
| ANTIBODY AGAINST CCR5 | 2003 |
|
RU2322454C2 |
| IMMUNOGENIC COMPOSITIONS BASED ON SYNTHETIC PEPTIDES MIMICKING ACTUAL DETERMINANTS OF HIV1 gp120 | 2014 |
|
RU2577132C1 |
| GENETIC CONSTRUCT FOR GENE EXPRESSION mNG_CD4-CXCR4, RECOMBINANT PLASMID rVSV_MNG_CD4-CXCR4 AND A RECOMBINANT VESICULAR STOMATITIS VIRUS STRAIN rVSV_mNG_CD4-CXCR4, WHICH PROVIDES TARGETED VIROLYSIS OF CELLS EXPOSING HIV-1 GP120/GP41 PROTEINS TROPISM X4 ON THEIR SURFACE | 2021 |
|
RU2768032C1 |
| GENETIC CONSTRUCT FOR EXPRESSION OF mNG_CD4-CCR5 GENES, RECOMBINANT PLASMID rVSV_mNG_CD4-CCR5 AND RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS rVSV_mNG_CD4-CCR5 PROVIDING TARGETED VIROLYSIS OF CELLS DISPLAYING HIV-1 PROTEINS GP120/GP41 OF R5 TROPISM ON THEIR SURFACE | 2021 |
|
RU2769125C1 |
| METHOD OF TREATING AND PREVENTING HIV INFECTION OF TYPE 1 SUBTYPE A | 2015 |
|
RU2600162C1 |
| ANTIBODY AND CHEMOKINE CONSTRUCTS AND USES THEREOF IN IMMUNOLOGICAL DISORDERS | 2001 |
|
RU2252786C2 |
| COMPLEX ANTI-HIV COMPOUND | 2004 |
|
RU2270690C1 |
| IMMUNOPROPHYLACTIC VACCINE AGAINST HIV BASED ON HIV-SPECIFIC ANTIBODIES | 2008 |
|
RU2505604C2 |
| RAPID SELECTION METHOD FOR HIV GP-120 VARIANTS | 2012 |
|
RU2603732C2 |
